Global Automated Breast Ultrasound Systems Overview
Automated Breast Ultrasound Systems (ABUS) Market was valued at US$ 2.34 Billion in 2024 and is projected to grow at a CAGR of 17.40% to reach US$ 11.4 Billion by 2034.
Automated breast ultrasound systems (ABUS) market report published by Prophecy Market Insights offers holistic view of various influencing factors and aims to answer all the target market related questions.
The research scope provides comprehensive market size, and other in-depth market information details such as, market growth supporting factors, restraining factors, trends, opportunities, market risk factors, market competition, product and services advancements and launches, product/services related regulations overview, and recent developments for the mentioned forecast period. In addition, the report provides key examination of market players operating in the specific market and analysis and outcomes related with the target market for more than 20 countries.
In the current research scope 2023 is considered as base year and 2024 is estimated year for market value/volume calculations. The report offers market estimates for the forecast period – 2024 to 2034. The report provides factual inputs and analysis based on primary and secondary research, which includes insights gained through in-depth interviews with primary research participants. Also, the data is gathered from authentic secondary sources and is verified by key opinion leaders in the target market. The in-house research is applied on gathered information to provide more accurate data points and reduce the margin of error. The in-house research and analysis efforts include various tools and 360o data analysis methodology.
Automated breast ultrasound systems (ABUS) market report segments the market on the basis of type, application, and region.
Automated breast ultrasound systems (ABUS) market by type:
- Automated Breast Ultrasound Systems(ABUS)
- Automated Breast Volume Scanner (ABVS)
Automated breast ultrasound systems (ABUS) market by application:
- Hospitals
- Diagnostic Imaging Centers
Automated breast ultrasound systems (ABUS) market by region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
The report expected to answer various target market related questions and offers insights on:
- Definition, description, overview of market growth influencing factors, and forecast for the target market
- Scope for related market in the forecast period
- Analysis and outcome for the automated breast ultrasound systems (ABUS) market by segment and region followed by countries
- Market segmentation, dominating segment and region followed by country along with market value, share, Y-o-Y growth, CAGR, forecast, and contribution in the market
- Key market player profiles, their recent developments, strategies, financial details, key competencies, presence by region, and product portfolio
- Valuable insights, data, and forecast that can be referenced to plan business strategies, to tap market opportunities, understand business related risks, derive business goals, to recognize trends, and understand target customer/end users
- Insights on recent technologies, pipeline products, regulations related with target market, market investment, and offers insights on political and economic factors that may influence market growth
- PEST Analysis, PORTER’s five forces analysis, opportunity map analysis, drivers and restraints impact analysis, and market attractiveness index
Key players in the automated breast ultrasound systems (ABUS) market include:
- GE Healthcare
- Hitachi Ltd.
- Koninklijke Philips N.V.
- Siemens AG
- SonoCine Inc.
- QView Medical,Inc.
- Seno Medical Instruments Inc.
- Volpara Solutions
- Delphinus Medical Technologies Inc.
- CapeRay
Prophecy Market Insights offers required customization on this report according to specific business related research requirements.
FAQs
The Automated Breast Ultrasound Systems (ABUS) Market is segmented into Type, Application and Region.
Market growth is driven by the increasing prevalence of breast cancer, advancements in breast imaging technologies, and the benefits of ABUS in supplemental breast cancer screening for dense breast tissue.
Challenges include the high cost of ABUS equipment, limited reimbursement policies, and potential competition from other breast imaging modalities, influencing the global Automated Breast Ultrasound Systems (ABUS) Market.
The report considers regions such as North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa as key areas for the Automated Breast Ultrasound Systems (ABUS) Market. North America is anticipated to dominate the market, driven by a high prevalence of breast cancer, widespread adoption of advanced medical technologies, and supportive healthcare infrastructure in the region.
The key players operating the target market includes GE Healthcare,Hitachi Ltd.,Koninklijke Philips N.V.,Siemens AG,SonoCine Inc.,QView Medical,Inc.,Seno Medical Instruments Inc.,Volpara Solutions,Delphinus Medical Technologies Inc.,CapeRay.